Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)

NCT01159847 is registered in ClinicalTrials.gov with European Foundation for the Study of Diabetes as lead sponsor.

NCT NCT01159847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01159847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)
Lead sponsor
European Foundation for the Study of Diabetes
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2010
Completion date
December 31, 2012
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes